Publications

Found 16 results
Author Title Type [ Year(Asc)]
Filters: Keyword is Glioma  [Clear All Filters]
2023
Bander ED, Kelly A, Ma X, Christos PJ, A Wernicke G, Stieg PE, Trichter S, Knisely JPS, Ramakrishna R, Schwartz TH.  2023.  Safety and efficacy of Cesium-131 brachytherapy for brain tumors.. J Neurooncol. 163(2):355-365.
2019
Zhang S, Chiang GChia-Yi, Magge RS, Fine HAlan, Ramakrishna R, Chang EWang, Pulisetty T, Wang Y, Zhu W, Kovanlikaya I.  2019.  MRI based texture analysis to classify low grade gliomas into astrocytoma and 1p/19q codeleted oligodendroglioma.. Magn Reson Imaging. 57:254-258.
Julie DAR, Ahmed Z, Karceski SC, Pannullo SC, Schwartz TH, Parashar B, A Wernicke G.  2019.  An overview of anti-epileptic therapy management of patients with malignant tumors of the brain undergoing radiation therapy.. Seizure. 70:30-37.
Zhang S, Chiang GChia-Yi, Magge RS, Fine HAlan, Ramakrishna R, Chang EWang, Pulisetty T, Wang Y, Zhu W, Kovanlikaya I.  2019.  Texture analysis on conventional MRI images accurately predicts early malignant transformation of low-grade gliomas.. Eur Radiol. 29(6):2751-2759.
Miller AM, Shah RH, Pentsova EI, Pourmaleki M, Briggs S, Distefano N, Zheng Y, Skakodub A, Mehta SA, Campos C et al..  2019.  Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid.. Nature. 565(7741):654-658.
2018
Souweidane MM, Kramer K, Pandit-Taskar N, Zhou Z, Haque S, Zanzonico P, Carrasquillo JA, Lyashchenko SK, Thakur SB, Donzelli M et al..  2018.  Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.. Lancet Oncol. 19(8):1040-1050.
2017
Kossatz S, Carney B, Schweitzer M, Carlucci G, Miloushev VZ, Maachani UB, Rajappa P, Keshari KR, Pisapia D, Weber WA et al..  2017.  Biomarker-Based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models.. Cancer Res. 77(8):2112-2123.
Zhou Z, Singh R, Souweidane MM.  2017.  Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment.. Curr Neuropharmacol. 15(1):116-128.
Ivasyk I, Morgenstern PF, Wembacher-Schroeder E, Souweidane MM.  2017.  Influence of an intratumoral cyst on drug distribution by convection-enhanced delivery: case report.. J Neurosurg Pediatr. 20(3):256-260.
Wang M, Kommidi H, Tosi U, Guo H, Zhou Z, Schweitzer ME, Wu LY, Singh R, Hou S, Law B et al..  2017.  A Murine Model for Quantitative, Real-Time Evaluation of Convection-Enhanced Delivery (RT-CED) Using an [F]-Positron Emitting, Fluorescent Derivative of Dasatinib.. Mol Cancer Ther. 16(12):2902-2912.
Huang Y, Rajappa P, Hu W, Hoffman C, Cisse B, Kim J-H, Gorge E, Yanowitch R, Cope W, Vartanian E et al..  2017.  A proangiogenic signaling axis in myeloid cells promotes malignant progression of glioma.. J Clin Invest. 127(5):1826-1838.
2016
Michelson N, Rincon-Torroella J, Quinones-Hinojosa A, Greenfield JP.  2016.  Exploring the role of inflammation in the malignant transformation of low-grade gliomas.. J Neuroimmunol. 297:132-40.
Singh R, Zhou Z, Tisnado J, Haque S, Peck KK, Young RJ, Tsiouris AJohn, Thakur SB, Souweidane MM.  2016.  A novel magnetic resonance imaging segmentation technique for determining diffuse intrinsic pontine glioma tumor volume.. J Neurosurg Pediatr. 18(5):565-572.
Guisado DI, Singh R, Minkowitz S, Zhou Z, Haque S, Peck KK, Young RJ, Tsiouris AJ, Souweidane MM, Thakur SB.  2016.  A Novel Methodology for Applying Multivoxel MR Spectroscopy to Evaluate Convection-Enhanced Drug Delivery in Diffuse Intrinsic Pontine Gliomas.. AJNR Am J Neuroradiol. 37(7):1367-73.
Uppstrom TJ, Singh R, Hadjigeorgiou GF, Magge R, Ramakrishna R.  2016.  Repeat surgery for recurrent low-grade gliomas should be standard of care.. Clin Neurol Neurosurg. 151:18-23.
2015
Margetis K, Schwartz TH.  2015.  Response.. J Neurosurg. 123(2):475-6.